The Human Bone Marrow May Offer an IL‐15‐Dependent Survival Niche for EOMES + Tr1‐Like Cells
European Journal of Immunology · 2025
DOI: 10.1002/eji.202451644 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Nadia Pulvirenti und 14 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Istituto Nazionale di Genetica Molecolare Romeo ed Enrica Invernizzi, Milan, Italy. Hauptthemen laut MEDLINE: T-Box Domain Proteins, Interleukin-15, Bone Marrow, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Italiana Sclerosi Multipla.
Abstract (Originalsprache)
Maintenance of memory T‐cells in the bone marrow and systemically depends on the homeostatic cytokines IL‐7 and IL‐15. An immunological memory may also exist for regulatory T‐cells. EOMES + type‐1 regulatory (Tr1)‐like cells have a rapid in vivo turnover, but whether they are short‐lived effector cells or are maintained long‐term has not been investigated. EOMES + Tr1‐like cells expressing GzmK were enriched among CD69 + Ki67 − T‐cells in the bone marrow of healthy donors, suggesting that they became quiescent and bone marrow‐resident. Conversely, CD4 + GzmB + effector T‐cells were excluded from the bone marrow‐resident fraction. The dichotomy between GzmK + and GzmB + T‐cells was observed both in healthy individuals and in multiple sclerosis patients, and also among CD8 + T‐cells. Intriguingly, bone marrow‐resident CD4 + memory T‐cells expressed increased levels of IL‐7Rα, while EOMES + Tr1‐like cells were consistently IL‐7Rα lo . However, EOMES + Tr1‐like cells expressed the IL‐2/15Rβ chain, and the latter was induced upon forced expression of EOMES in primary human CD4 + T‐cells. Finally, IL‐15 rescued EOMES + Tr1‐enriched populations from death by neglect but was not required for CD4 + memory T‐cell survival. These findings suggest that the bone marrow may provide a survival niche for EOMES + Tr1‐like cells. The different IL‐7 and IL‐15 receptor expression patterns of CD4 + memory T‐cells and EOMES + Tr1‐like cells suggest furthermore that they compete for different homeostatic niches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fondazione Istituto Nazionale di Genetica Molecolare Romeo ed Enrica Invernizzi, Milan, Italy.
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy.
- IRCCS Ospedale Policlinico San Martino, Genova, Italy.
- Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
- Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale, Maggiore Policlinico, Milan, Italy.
- Biological Resource Center Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore, Policlinico, Milan, Italy.
ORCID-Profile: Giacomo Boffa, Jens Geginat
Förderung
- Fondazione Italiana Sclerosi Multipla
Zitieren
APA
Pulvirenti, N., Vasco, C., Righetti, C., Dadova, P., Boffa, G., Laroni, A., Vigo, T., Raiola, A. M., Crosti, M. C., Maglie, S., Valenti, L., Prati, D., Abrigani, S., Uccelli, A., & Geginat, J. (2025). The Human Bone Marrow May Offer an IL‐15‐Dependent Survival Niche for EOMES + Tr1‐Like Cells. European Journal of Immunology. https://doi.org/10.1002/eji.202451644
Vancouver
Pulvirenti N, Vasco C, Righetti C, Dadova P, Boffa G, Laroni A, et al. The Human Bone Marrow May Offer an IL‐15‐Dependent Survival Niche for EOMES + Tr1‐Like Cells. European Journal of Immunology. 2025. doi:10.1002/eji.202451644
BibTeX
@article{Pulvirenti2025,
author = {Pulvirenti, Nadia and Vasco, Chiara and Righetti, Camilla and Dadova, Petra and Boffa, Giacomo and Laroni, Alice and Vigo, Tiziana and Raiola, Anna Maria and Crosti, Maria Cristina and Maglie, Stefano and Valenti, Luca and Prati, Daniele and Abrigani, Sergio and Uccelli, Antonio and Geginat, Jens},
title = {The Human Bone Marrow May Offer an IL‐15‐Dependent Survival Niche for EOMES + Tr1‐Like Cells},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.202451644}
}
EUVIMED